Study: NCT01303783

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 30 mg
Description: 30 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 30 mg
Description: 30 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 30 mg
Description: 30 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 30 mg
Description: 30 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 60 mg
Description: 60 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 60 mg
Description: 60 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (Adalat, BAYA1040), 60 mg
Description: 60 mg nifedipine as tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3 different placebo tablets corresponding nifedipine doses and 1 placebo capsule corresponding to candesartan doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 16 mg
Description: 16 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 16 mg
Description: 16 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 16 mg
Description: 16 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 16 mg
Description: 16 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 32 mg
Description: 32 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 32 mg
Description: 32 mg of candesartan as capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (Atacand), 32 mg
Description: 32 mg of candesartan as capsule